Welcome to our dedicated page for Trinity Capital news (Ticker: TRIN), a resource for investors and traders seeking the latest updates and insights on Trinity Capital stock.
Trinity Capital Inc. reports developments as an alternative asset manager and specialty lender focused on private credit for growth-oriented companies. Its recurring news includes quarterly financial results, net investment income, NAV movement, new commitments, funded investments, repayments, exits, and portfolio activity across Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences.
Company updates also cover secured loans, equipment financings, warrant and equity investments, sponsored investment funds, SBIC-related activity, and growth-capital facilities for portfolio companies in technology, life sciences, medical technology, energy infrastructure, and other innovation-driven markets.
Trinity Capital (Nasdaq: TRIN) reported Q1 2026 results: total investment income $90.1M (up 37.8% YoY), net investment income $44.5M or $0.53 per share, NAV $1.2B or $13.27 per share, and ROAE 15.8%. Q1 gross investments funded were $306.3M with $238.3M of exits/repayments. Net leverage was ~115% and available liquidity was ~$282.1M. The Board declared monthly dividends of $0.17 for Apr–Jun 2026.
Parafin announced an upsized and renewed warehouse credit facility with Silicon Valley Bank (SVB), new A-note lender EverBank, and Trinity Capital (NASDAQ: TRIN) on May 5, 2026. The expansion builds on a prior $125 million facility from 2024 and is said to increase borrowing capacity and lower Parafin’s cost of capital. Parafin noted it has funded over $2 billion to nearly 50,000 small businesses to date and that most fundings go to repeat borrowers. The facility aims to support embedded financing across platforms like Amazon, DoorDash, Gusto, TikTok Shop, and Walmart.
Trinity Capital (Nasdaq: TRIN) announced that its sponsored fund, Trinity Capital SBIC LP, received an SBIC license from the U.S. Small Business Administration on May 4, 2026. This is the firm's third sponsored SBIC license since 2008 and follows prior SBIC deployments totaling $734 million.
As an SBIC, the Fund is eligible for up to $175 million of SBA‑guaranteed debentures at a two‑to‑one debt‑to‑investor commitments ratio, supporting a potential total fund size of $262.5 million if the target $87.5 million fundraising is achieved.
Trinity Capital (Nasdaq: TRIN) committed up to $35 million in equipment financing to Torus to support expansion of its new GigaOne manufacturing and assembly facility.
The financing targets scaling production of American-made distributed mesh energy systems for utilities, data centers, manufacturers, and commercial and industrial customers.
Trinity Capital (Nasdaq: TRIN) committed $30 million in growth capital to Iantrek to accelerate commercial expansion and advance its bio-interventional ophthalmic surgery product pipeline.
The debt facility will fund commercialization of AlloFlo Uveo, regulatory and development activities, scaling manufacturing and distribution, and market access efforts to broaden physician adoption.
Trinity Capital (Nasdaq: TRIN) committed $50 million in growth capital to Cala Health to support commercial expansion of its wearable tremor therapy.
Cala Health commercializes the Cala kIQ System, an FDA-cleared wrist-worn device delivering individualized noninvasive nerve stimulation for essential tremor and Parkinson's disease, prescribed for at-home use to help patients perform daily activities.
Trinity Capital (Nasdaq: TRIN) reported first quarter 2026 portfolio activity: $306 million funded and $395 million of new commitments.
Funding comprised $236M secured loans, $54M equipment financings and $16M warrant/equity investments; commitments included $304M secured loans and $75M equipment financings. Repayments and exits totaled ~$238M. Full 2026 results due May 6, 2026.
Trinity Capital (Nasdaq: TRIN) will release first quarter 2026 financial results on May 6, 2026 at 8:00 a.m. ET and host a conference call the same day at 12:00 p.m. ET. A taped replay is available until May 13, 2026; a webcast replay will remain on the company website for 90 days.
The company provided dial‑in numbers, a conference ID (TRINQ126), and a webcast link via its investor relations site for live and replay access.
Trinity Capital (Nasdaq: TRIN) committed $50 million in a debt term loan to Sage Health on March 27, 2026 to support expansion of senior-focused primary care and wellness centers in medically underserved areas. The financing brings Sage's total capital raised to $170 million.
Sage limits physicians to 500 patients each, operates in primary-care shortage neighborhoods, and integrates primary care, wellness, and care coordination to manage chronic conditions. Armentum Partners served as Sage's debt capital advisor.
Trinity Capital (Nasdaq: TRIN) declared a monthly regular dividend of $0.17 per share for April, May and June 2026.
Declaration date for all three payments was March 18, 2026; record dates are April 15, May 15 and June 11, 2026, with payment dates April 30, May 29 and June 30, 2026. The company said it targets distributing roughly 90%–100% of taxable quarterly income to maintain RIC tax treatment.